Por: New York Daily News Health September 24, 2022
Pfizer is sinking $120 million into a Michigan factory to drastically increase its production and supply of its oral COVID-19 treatment, the pharmaceutical company announced Monday. The investment, which will create more than 250 high-skilled jobs at the Kalamazoo plant, will be used to ramp up production of the active ingredient in Paxlovid. “Pfizer Global Supply has made the impossible possible, making billions of vaccine doses and now... + full article
CNBC USA Politics September 29, 2022
A crosswalk signal is seen outside the U.S. Supreme Court building in Washington, U.S., June 27, 2022.Elizabeth Frantz ReutersThe Supreme Court starting Monday will allow members of the public to attend oral argument hearings for the first time since the Covid-19 lockdown of... + más
David Shapiro: US Supreme Court vs. states’ highest courts: We are giving kids the wrong message. | Chicago Tribune
Justice Ketanji Brown Jackson makes Supreme Court debut | New York Daily News
The Hill USA Health September 27, 2022
Pfizer on Monday announced it has submitted an application to the Food and Drug Administration (FDA) seeking authorization of its bivalent COVID-19 booster shot for children between the ages of 5 and 11. In a press release, Pfizer said it has requested authorization of a 10... + más
Health Care — Pfizer asks to give omicron boosters to young kids | The Hill
Health Care — Moderna seeks green light for kids’ omicron booster | The Hill
The Hill USA Health September 24, 2022
Pfizer announced on Thursday it has reached an agreement to supply up to six million courses of its COVID-19 antiviral Paxlovid to the Global Fund to get treatment to low and middle-income countries. This supply agreement was made as part of the Global Fund’s COVID19 Response... + más
Pfizer pledges $120M to produce oral COVID-19 treatment Paxlovid at Michigan factory | New York Daily News
Health Care — White House: Graham abortion bill would be a ‘crisis’ | The Hill
The Verge USA Health September 24, 2022
Moderna is suing Pfizer over its coronavirus vaccineModerna is suing Pfizer over its coronavirus vaccine / The company is filing patent infringement lawsuits against Pfizerp>span:first-child]:text-black text-blurple>By Aug 26, 2022, 12:37 PM UTC Share this story... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
Los Angeles Times USA Nation September 24, 2022
As residents prepare to roll up their sleeves for a third, fourth or even fifth dose of COVID-19 vaccine, some may be wondering: Do I need to stick with the same brand, or is it safe to mix it up? When it comes to the new COVID-19 Omicron bivalent booster, the answer is, yes,... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
PennLive USA Nation September 24, 2022
By Luke Money and Rong-Gong Lin II, Los Angeles TimesLOS ANGELES — As residents prepare to roll up their sleeves for a third, fourth or even fifth dose of COVID-19 vaccine, some may be wondering: Do I need to stick with the same brand, or is it safe to mix it up?When it comes... + más
The Atlantic USA Opinion September 24, 2022
What we know about Paxlovid, how to handle a positive test, and when to get a boosterAllen J. Schaben / GettySeptember 23, 2022, 7 AM ETAbout the author: is a staff writer at The Atlantic. For almost two years, answering readers’ COVID-19 questions was part of my job as the... + más
Dreaded Side Effect Rears Its Ugly Head in Latest COVID Variant | The Daily Beast
New guidance released on diagnosing, treating long COVID symptoms | ABC News
About iurex | Privacy Policy | Disclaimer |